Rheumatology

Systemic Lupus Erythematosus

Conference Reporter® Podcast: Access and Convenience in a Changing Systemic Lupus Erythematosus Treatment Landscape

conference reporter by Danielle Gatti-Palumbo, PharmD, BCACP

Overview

Expanding treatment options for systemic lupus erythematosus raise practical questions about access and convenience. In a podcast discussion after the RhAPP Seventh Annual National Conference 2026, our expert explains how patient preferences, insurance coverage, and cost influence treatment choices and how clinical teams can help patients navigate access barriers.

Following this presentation, featured expert Danielle Gatti-Palumbo, PharmD, BCACP, was interviewed by Conference Reporter Associate Editor-in-Chief Christopher Ontiveros, PhD. Clinical perspectives from Dr Gatti-Palumbo on these findings are presented here.

References

Bell CF, Lau M, Lee M, Poulos C. Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE. Clin Rheumatol. 2021;40(2):581-590. doi:10.1007/s10067-020-05226-w

Hart J. Emerging therapies in SLE: what’s next in clinical care [session: Plenary]? Session presented at: Rheumatology Advanced Practice Providers Seventh Annual National Conference 2026; September 23-26, 2026; Las Vegas, NV.

Wallace ZS, Harkness T, Fu X, Stone JH, Choi HK, Walensky RP. Treatment delays associated with prior authorization for infusible medications: a cohort study. Arthritis Care Res (Hoboken). 2020;72(11):1543-1549. doi:10.1002/acr.24062

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by Rheumatology Advanced Practice Providers.